191 related articles for article (PubMed ID: 30514197)
1. Development Insights of Surface Modified Lipid Nanoemulsions of Dihydroartemisinin for Malaria Chemotherapy: Characterization, and in vivo Antimalarial Evaluation.
Umeyor CE; Obachie O; Chukwuka R; Attama A
Recent Pat Biotechnol; 2019; 13(2):149-165. PubMed ID: 30514197
[TBL] [Abstract][Full Text] [Related]
2. Mechanism-based model of parasite growth and dihydroartemisinin pharmacodynamics in murine malaria.
Patel K; Batty KT; Moore BR; Gibbons PL; Bulitta JB; Kirkpatrick CM
Antimicrob Agents Chemother; 2013 Jan; 57(1):508-16. PubMed ID: 23147722
[TBL] [Abstract][Full Text] [Related]
3. Formulation development and evaluation of the anti-malaria properties of sustained release artesunate-loaded solid lipid microparticles based on phytolipids.
Chinaeke EE; Chime SA; Onyishi VI; Attama AA; Okore VC
Drug Deliv; 2015; 22(5):652-65. PubMed ID: 24479677
[TBL] [Abstract][Full Text] [Related]
4. Arteether nanoemulsion for enhanced efficacy against Plasmodium yoelii nigeriensis malaria: an approach by enhanced bioavailability.
Dwivedi P; Khatik R; Chaturvedi P; Khandelwal K; Taneja I; Raju KS; Dwivedi H; Singh SK; Gupta PK; Shukla P; Tripathi P; Singh S; Tripathi R; Wahajuddin ; Paliwal SK; Dwivedi AK; Mishra PR
Colloids Surf B Biointerfaces; 2015 Feb; 126():467-75. PubMed ID: 25616971
[TBL] [Abstract][Full Text] [Related]
5. Sustained-release liquisolid compact tablets containing artemether-lumefantrine as alternate-day regimen for malaria treatment to improve patient compliance.
Nnamani PO; Ugwu AA; Ibezim EC; Kenechukwu FC; Akpa PA; Ogbonna JN; Obitte NC; Odo AN; Windbergs M; Lehr CM; Attama AA
Int J Nanomedicine; 2016; 11():6365-6378. PubMed ID: 27932882
[TBL] [Abstract][Full Text] [Related]
6. Development of a pharmacodynamic model of murine malaria and antimalarial treatment with dihydroartemisinin.
Gibbons PL; Batty KT; Barrett PH; Davis TM; Ilett KF
Int J Parasitol; 2007 Dec; 37(14):1569-76. PubMed ID: 17585920
[TBL] [Abstract][Full Text] [Related]
7. Stearylamine Liposomal Delivery of Monensin in Combination with Free Artemisinin Eliminates Blood Stages of Plasmodium falciparum in Culture and P. berghei Infection in Murine Malaria.
Rajendran V; Rohra S; Raza M; Hasan GM; Dutt S; Ghosh PC
Antimicrob Agents Chemother; 2015 Dec; 60(3):1304-18. PubMed ID: 26666937
[TBL] [Abstract][Full Text] [Related]
8. Development of SMEDDS using natural lipophile: application to beta-Artemether delivery.
Mandawgade SD; Sharma S; Pathak S; Patravale VB
Int J Pharm; 2008 Oct; 362(1-2):179-83. PubMed ID: 18652886
[TBL] [Abstract][Full Text] [Related]
9. Development, characterization and antimalarial efficacy of dihydroartemisinin loaded solid lipid nanoparticles.
Omwoyo WN; Melariri P; Gathirwa JW; Oloo F; Mahanga GM; Kalombo L; Ogutu B; Swai H
Nanomedicine; 2016 Apr; 12(3):801-809. PubMed ID: 26724538
[TBL] [Abstract][Full Text] [Related]
10. Characterising the effect of antimalarial drugs on the maturation and clearance of murine blood-stage Plasmodium parasites in vivo.
Khoury DS; Cromer D; Elliott T; Soon MSF; Thomas BS; James KR; Best SE; Aogo RA; Engel JA; Gartlan KH; Akter J; Sebina I; Haque A; Davenport MP
Int J Parasitol; 2017 Dec; 47(14):913-922. PubMed ID: 28864033
[TBL] [Abstract][Full Text] [Related]
11. Plasmodium berghei: parasite clearance after treatment with dihydroartemisinin in an asplenic murine malaria model.
Moore BR; Jago JD; Batty KT
Exp Parasitol; 2008 Apr; 118(4):458-67. PubMed ID: 18023429
[TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo anti-malarial activity of novel harmine-analog heat shock protein 90 inhibitors: a possible partner for artemisinin.
Bayih AG; Folefoc A; Mohon AN; Eagon S; Anderson M; Pillai DR
Malar J; 2016 Dec; 15(1):579. PubMed ID: 27903279
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and evaluation of antimalarial potential of polyphosphazene linked combination therapy of primaquine and dihydroartemisinin.
Kumar S; Singh RK; Sharma R; Murthy RS; Bhardwaj TR
Eur J Pharm Sci; 2015 Jan; 66():123-37. PubMed ID: 25312346
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and Evaluation of Substituted Poly(organophosphazenes) as a Novel Nanocarrier System for Combined Antimalarial Therapy of Primaquine and Dihydroartemisinin.
Kumar S; Singh RK; Murthy RS; Bhardwaj TR
Pharm Res; 2015 Aug; 32(8):2736-52. PubMed ID: 25777611
[TBL] [Abstract][Full Text] [Related]
15. Artemisinin and artemisinin plus curcumin liposomal formulations: enhanced antimalarial efficacy against Plasmodium berghei-infected mice.
Isacchi B; Bergonzi MC; Grazioso M; Righeschi C; Pietretti A; Severini C; Bilia AR
Eur J Pharm Biopharm; 2012 Apr; 80(3):528-34. PubMed ID: 22142592
[TBL] [Abstract][Full Text] [Related]
16. Improved antimalarial activity of caprol-based nanostructured lipid carriers encapsulating artemether-lumefantrine for oral administration.
Akpa PA; Ugwuoke JA; Attama AA; Ugwu CN; Ezeibe EN; Momoh MA; Echezona AC; Kenechukwu FC
Afr Health Sci; 2020 Dec; 20(4):1679-1697. PubMed ID: 34394228
[TBL] [Abstract][Full Text] [Related]
17. Formulation design and in vivo antimalarial evaluation of lipid-based drug delivery systems for oral delivery of β-arteether.
Memvanga PB; Préat V
Eur J Pharm Biopharm; 2012 Sep; 82(1):112-9. PubMed ID: 22609572
[TBL] [Abstract][Full Text] [Related]
18. Antimalarial activity of new dihydroartemisinin derivatives. 7. 4-(p-substituted phenyl)-4(R or S)-[10(alpha or beta)-dihydroartemisininoxy]butyric acids.
Lin AJ; Zikry AB; Kyle DE
J Med Chem; 1997 Apr; 40(9):1396-400. PubMed ID: 9135037
[TBL] [Abstract][Full Text] [Related]
19. Arthemeter-loaded lipid nanoparticles produced by modified thin-film hydration: Pharmacokinetics, toxicological and in vivo anti-malarial activity.
Aditya NP; Patankar S; Madhusudhan B; Murthy RS; Souto EB
Eur J Pharm Sci; 2010 Aug; 40(5):448-55. PubMed ID: 20493255
[TBL] [Abstract][Full Text] [Related]
20. In vivo Antiplasmodial Activity of Curcumin-Loaded Nanostructured Lipid Carriers.
Rashidzadeh H; Salimi M; Sadighian S; Rostamizadeh K; Ramazani A
Curr Drug Deliv; 2019; 16(10):923-930. PubMed ID: 31663477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
